Jones RL - Search Results

1

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study.

Constantinidou A, Sauve N, Stacchiotti S, Blay JY, Vincenzi B, Grignani G, Rutkowski P, Guida M, Hindi N, Klein A, Thibaud V, Sufliarsky J, Desar I, Steeghs N, Litiere S, Gelderblom H, Jones RL. Constantinidou A, et al. Among authors: jones rl. ESMO Open. 2020 Aug;5(4):e000787. doi: 10.1136/esmoopen-2020-000787. ESMO Open. 2020. PMID: 32847839 Free PMC article.

2

Differential sensitivity of liposarcoma subtypes to chemotherapy.

Jones RL, Fisher C, Al-Muderis O, Judson IR. Jones RL, et al. Eur J Cancer. 2005 Dec;41(18):2853-60. doi: 10.1016/j.ejca.2005.07.023. Epub 2005 Nov 10. Eur J Cancer. 2005. PMID: 16289617

3

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.

Grosso F, Jones RL, Demetri GD, Judson IR, Blay JY, Le Cesne A, Sanfilippo R, Casieri P, Collini P, Dileo P, Spreafico C, Stacchiotti S, Tamborini E, Tercero JC, Jimeno J, D'Incalci M, Gronchi A, Fletcher JA, Pilotti S, Casali PG. Grosso F, et al. Among authors: jones rl. Lancet Oncol. 2007 Jul;8(7):595-602. doi: 10.1016/S1470-2045(07)70175-4. Lancet Oncol. 2007. PMID: 17586092

4

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.

Jones RL, Salter J, A'Hern R, Nerurkar A, Parton M, Reis-Filho JS, Smith IE, Dowsett M. Jones RL, et al. Breast Cancer Res Treat. 2009 Jul;116(1):53-68. doi: 10.1007/s10549-008-0081-7. Epub 2008 Jul 1. Breast Cancer Res Treat. 2009. PMID: 18592370

5

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis.

Constantinidou A, Jones RL, Scurr M, Al-Muderis O, Judson I. Constantinidou A, et al. Among authors: jones rl. Eur J Cancer. 2009 Nov;45(17):2930-4. doi: 10.1016/j.ejca.2009.08.016. Epub 2009 Sep 18. Eur J Cancer. 2009. PMID: 19767198 Clinical Trial.

6

Chemotherapy in clear cell sarcoma.

Jones RL, Constantinidou A, Thway K, Ashley S, Scurr M, Al-Muderis O, Fisher C, Antonescu CR, D'Adamo DR, Keohan ML, Maki RG, Judson IR. Jones RL, et al. Med Oncol. 2011 Sep;28(3):859-63. doi: 10.1007/s12032-010-9502-7. Med Oncol. 2011. PMID: 20390470

7

Beyond triple-negative breast cancer: the need to define new subtypes.

Constantinidou A, Jones RL, Reis-Filho JS. Constantinidou A, et al. Among authors: jones rl. Expert Rev Anticancer Ther. 2010 Aug;10(8):1197-213. doi: 10.1586/era.10.50. Expert Rev Anticancer Ther. 2010. PMID: 20735307 Review.

8

Advanced aggressive fibromatosis: Effective palliation with chemotherapy.

Constantinidou A, Jones RL, Scurr M, Al-Muderis O, Judson I. Constantinidou A, et al. Among authors: jones rl. Acta Oncol. 2011 Apr;50(3):455-61. doi: 10.3109/0284186X.2010.509105. Epub 2010 Aug 30. Acta Oncol. 2011. PMID: 20799916

9

Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer.

Jones RL, Rojo F, A'Hern R, Villena N, Salter J, Corominas JM, Servitja S, Smith IE, Rovira A, Reis-Filho JS, Dowsett M, Albanell J. Jones RL, et al. J Clin Pathol. 2011 Feb;64(2):130-5. doi: 10.1136/jcp.2010.082966. Epub 2010 Dec 8. J Clin Pathol. 2011. PMID: 21148141

10

Role of palliative chemotherapy in advanced epithelioid sarcoma.

Jones RL, Constantinidou A, Olmos D, Thway K, Fisher C, Al-Muderis O, Scurr M, Judson IR. Jones RL, et al. Am J Clin Oncol. 2012 Aug;35(4):351-7. doi: 10.1097/COC.0b013e3182118cf7. Am J Clin Oncol. 2012. PMID: 21422990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,355 results

Search Page